US FDA Pushes for New Methods to Replace Animal Testing ...

Health Agencies Ramp Up Push for Alternatives to Animal Testing

Federal regulators on March 18 issued draft guidance to help manufacturers use alternatives to animal testing during drug development, while the National Institutes of Health (NIH) pledged to invest $150 million in research methods that reduce the use of animals. The Food and Drug Administration’s draft guidance says in part that new approaches, such as using organoids—replica organs typically created with stem cells—and computer simulations can…

FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development

(MedPage Today) -- Drug developers will be able to use alternatives to animal testing and possibly get new products to market faster under draft guidance issued Wednesday by the FDA. In a press release, officials said the guidance advances the...

FDA and NIH announce more initiatives to reduce animal testing in drug development

FDA released guidance to help drug companies assess their products without animals. NIH will offer grants to find alternatives.

US FDA pushes for new methods to replace animal testing ...

FDA seeks to encourage fewer animal studies with new draft guidance

The FDA unveiled long-awaited draft guidance on how biopharma companies can validate new approaches for toxicology and other early-phase safety studies, potentially reducing the animal testing that's long been used to assess the risks of ...

FDA Proposes Guidance Advancing Non-Animal Methods in Drug Development

New policy signals major shift toward human-relevant science and away from outdated animal testing WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) today released a sweeping new draft guidance, “General Considerations for the Use of New Approach Methodologies (NAMs) in Drug Development,” marking a pivotal step toward replacing animal testing with more predictive, ... Read more The post FDA Proposes Guidance Advancing Non-Animal Met…